Biotech regrew knee cartilage in mice and starts clinical trials

Researchers regrew knee cartilage in mice, and a biotech company has begun clinical trials of the treatment in humans. The approach is being likened to a GLP-1-style therapy for muscles and cartilage.

• Knee cartilage was regenerated in mice
• The biotech has moved to human clinical trials
• The treatment is compared to GLP-1 for muscles and cartilage